Research

AHA Achieves 2010 Goal of Reducing Death from Heart Disease  More.
Research Administration

The AHA has implemented a Web-based system, Grants@Heart, to manage the application, peer review and awards processes. The system is accessible 24/7 from any location with internet connection.  Web browsers are currently limited to Internet Explorer 5.0 for PC users and Safari for Mac users.  This secure site requires all users to have a username and password for access.

Information for the Applicant
Within Grants@Heart an applicant completes the online application and submits it to his/her institutional grants officer.  The grants officer is responsible for submitting the application to AHA.  Other parties associated with an application (such as department head, collaborating-investigator, consultant, etc.) provide their documents to the applicant and the applicant uploads them to his/her application.  The online application will be available on June 1 for July 2010 deadlines.
Find out more in the Applicant Information Guide.

Information for Peer Reviewers
Within Grants@Heart peer reviewers can review applications, write critiques and complete other tasks online.  The peer review meetings are paperless and the majority of the meetings are now virtual.
Find out more in the Peer Review Guidelines.

Information for Grants and Fiscal Officers
The Grants Officer is responsible for reviewing applications and final submission to AHA by the deadline
Fiscal Officers can access all awards from their institution.
Find out more for the Fiscal Officer and Grants Officer.

 

funding

Funding Opportunities 
See what AHA programs are available for July 2010 deadlines. 

Funding & News by Other Organizations & Federal Agencies

 
trophy
 
group

Current Awardees
The association's research dollars support the most worthy projects selected from a substantial pool of applicants. 

Nobel Prize Winners Associated With the American Heart Association
The American Heart Association is recognized as a worldwide leader in cardiovascular science.  Countless top cardiovascular scientists throughout the world are linked in some way with us.  This list of Nobel Prize recipients confirms the claim that we are a focal point for excellence in cardiovascular research.

Peer Review
A peer review committee reviews and grades applications for research support on the basis of scientific merit. 

Focused Research
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded  $6 million to the University of Pennsylvania, University of Texas Southwestern Medical Center and University of Minnesota to study the development and mechanisms of generating new cardiac muscle cells. 

Research Facts
Research is a major weapon in our fight against cardiovascular diseases .  Read about our strategy to fight CVD and stroke, our commitment to support early career investigators, our goals for the future, our distribution of dollars and much more.

programs and tools
 

Help the AHA to be the solution for women and heart disease research.

The American Heart Association has been instrumental in increasing awareness that cardiovascular disease (CVD) is the No. 1 killer of Americans.  Despite important advances, CVD accounts for 37 percent of all deaths in women, nearly as many as the next five leading causes of death combined.  In the most recent year for which data are available, cardiovascular disease was the cause of death in 454,613 females, while all forms of cancer combined to kill 268,800.  Cardiovascular deaths in women represent over half (52.6 percent) of all of deaths from CVD.  Since 1984, the number of CVD deaths for females has exceeded those for males every year.

A leading priority of the American Heart Association is to fund research that increases an understanding of the causes, treatments and prevention of cardiovascular diseases and stroke.  This is most important in areas where there are critical gaps in knowledge… cardiovascular disease in women clearly includes many such gaps.  There is an urgent need to accelerate scientific efforts that provide for the development of new knowledge in preventing death and disability from CVD in women.

To this end, the AHA is seeking to secure financial support to be able to submit a Request for Applications (RFA) once there are sufficient funds to support this important research effort to advance CVD science in women.  To maximize knowledge discovery, it is imperative to have a mechanism that fosters institutional interaction among research facilities and collaboration across multiple areas of discipline-focused inquiry.  Therefore, the model for this funding initiative’s structure will be the ASA-Bugher Foundation Centers for Stroke Prevention Research.  This network of three institutional centers provides fellowship training and conducts research projects enhanced by cross-center collaboration.

When it is issued, the RFA’s focus will be the specified areas below: 

Heart attacks (myocardial infarction) in younger women.  Unfortunately, younger and middle-aged women who have a heart attack have poorer recovery than men, including higher mortality.  While recent research has clarified a number of aspects of the differences in the distribution and functional consequences of atherosclerosis in women, there remains an urgent need to understand the mechanisms which contribute to the higher death rate after heart attack among younger women.  

Arrhythmias.  It is critical that we pursue research to reduce the number of women experiencing and dying from sudden cardiac arrest.  It is known that women are at higher risk of certain types of arrhythmias (e.g., drug-induced torsades), warranting further investigation into electrophysiologic mechanisms.

Heart failure in older women.  There is a growing population of older women living with heart failure, creating an important public health issue with both human disease burden and societal economic implications.  Importantly, there are both the usual etiologies of heart failure in women (ischemic heart disease, viral cardiomyopathy), but also other pathologies specifically important for or over-represented in women (e. g., peri-partum cardiomyopathy, valvular heart diseases, and diastolic dysfunction). Research is needed to better define the pathophysiologies and to define optimal treatment approaches.


Print   Email

Links on This Site
Application Deadlines

Research Contact Information

Funding Opportunities


Scientific Sessions 2010 Brochure

Scientific Sessions
Nov. 13–17, 2010
Chicago, Ill.

AHA/ASA Professional Membership has its benefits! 
Join or Renew today and save on registration in 2010!

Science News Coverage from Sessions 2009 



Privacy Policy | Copyright | Ethics Policy | Conflict of Interest Policy | Linking Policy | Diversity
© 2010 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.
   BBB